Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG (pH4, new vs original process) for primary immune thrombocytopenia
CTR20180860Phase 3Active
- Sponsor
- Green Cross China
- Start
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of immune globulin in immune thrombocytopenia (ITP), sponsored by Green Cross China. Started Dec 2018; status: active.
02
Drugs
immune globulin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on CTR20180860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180860.